March 7, 2025
TOPLINE: A low-dose (40 mg) modified formulation of minocycline hydrochloride (DFD-29) was better tolerated and more effective than doxycycline and placebo in patients with moderate to […]
March 6, 2025
In a recent case report, a novel immunophenotyping platform featuring high-parameter flow cytometry of peripheral blood mononuclear cells (PBMCs) enabled physicians to discover a unique skin […]
March 6, 2025
TOPLINE: Upadacitinib, a Janus kinase 1 inhibitor, demonstrated comparable safety and effectiveness over 2 years in patients with moderate to severe atopic dermatitis (AD), regardless of […]
March 5, 2025
TOPLINE: At-home light-emitting diode (LED) devices using red and/or blue light significantly reduced acne lesions and showed a favorable safety profile in patients with mild to […]
March 4, 2025
TOPLINE: In a study of patients with advanced melanoma, the prevalence of cutaneous immune–related adverse events (cirAEs) associated with nivolumab/relatlimab combination therapy was 21.5%, with rash […]
March 3, 2025
Rosacea treatment is a marathon — not a sprint — and there’s a need for increased emphasis on a patient-centric approach to management that emphasizes patient […]
February 28, 2025
TOPLINE: Early initiation of hydroxychloroquine (HCQ) in patients with cutaneous lupus erythematosus (CLE) reduces the risk for progression to systemic lupus erythematosus (SLE) by 87% over […]
February 27, 2025
TOPLINE: Poor adherence to healthy dietary patterns was associated with an increased likelihood of severe psoriasis symptoms in adults, a UK study found. METHODOLOGY: Researchers conducted […]
February 27, 2025
TOPLINE: A study found that both dermatomyositis (DM) and clinically amyopathic dermatomyositis (CADM) were commonly misdiagnosed as inflammatory skin disease (ISD), particularly CADM, which was also […]